Xylocaine- Mpf (lidocaine Hcl ) Injection, Solution
Product Images NDC 51662-1604

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Xylocaine- Mpf (lidocaine Hcl ) (NDC 51662-1604). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pouch Labeling (51662 1604 2 Pouch Labeling Sept 2022)

Packaging label for XYLOCAINE- MPF (LIDOCAINE HCl) Injection, USP 2% 100 mg/5 mL (20 mg/mL) in a 5 mL vial. Label includes NDC 51662-1604-2, lot number, expiration date, route of administration (caudal, epidural, infiltration, nerve block), and manufacturer HF Acquisition Co LLC, DBA HealthFirst. Label notes sterile, nonpyrogenic status and storage instructions.*

FDA Label Image

Case Labeling (51662 1604 3 Case Labeling Sept 2022)

XYLOCAINE-MPF (LIDOCAINE HCl) Injection, USP 2% 100 mg/5 mL (20 mg/mL) in a 5 mL vial. The label indicates a case containing 25 vials, sterile and nonpyrogenic, for infiltration and nerve block including caudal and epidural use. Manufactured by HF Acquisition Co LLC, DBA HealthFirst, Mukilteo, WA. The NDC shown is 51662-1664-3.*

FDA Label Image

Rfid Labeling (51662 1604 3 Serialized Rfid Labeling Sept 2022)

Small clear plastic pouch with a white label featuring a barcode, numeric codes, and text instructing to see the manufacturer's package insert. Label includes alert 'RX ONLY' and manufacturer details: HF Acquisition Co., LLC, Mukilteo, WA 98275.*

FDA Label Image

Max (Max Recommended Dosage)

A data table titled 'Recommended Dosages' listing various procedures for XYLOCAINE-MPF (Lidocaine HCl) injection, solution. The table includes columns for procedure names, concentration (mg/mL), volume (mL), and total dose (mg), with entries detailing dosing recommendations for procedures such as infiltration, peripheral nerve blocks, epidural, spinal, and other regional anesthetics.*

FDA Label Image

Precautions (Precautions)

A data table listing drug classes and example drugs in each class. Classes include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs. Examples include lidocaine under Local anesthetics and acetaminophen under Other drugs.*

FDA Label Image

S1 (Structure 1)

Chemical structure diagram of Lidocaine Hydrochloride showing the molecular arrangement including aromatic ring, amide group, and two ethyl groups attached to nitrogen, alongside the hydrochloride component.*

FDA Label Image

S2 (Structure 2)

Chemical structure diagram of Lidocaine HCl, showing its molecular arrangement with aromatic ring and functional groups, corresponding to the active ingredient in XYLOCAINE- MPF injection solution.*

FDA Label Image

Vial Label (Vial Label Sept 2022)

Label for Xylocaine-MPF (lidocaine HCl injection, USP) 2% solution, 20 mg per mL, in a 5 mL single dose vial. The label states the product is methylparaben free, intended for infiltration and nerve block including caudal and epidural use. It is sterile, nonpyrogenic, and can be resterilized by autoclaving. The labeler is Fresenius Kabi, Lake Zurich, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.